A comprehensive overview of thyroid eye disease
This one day seminar chaired and delivered by a multi-disciplinary faculty of experts will cover current evidence based concepts and exciting advances in Thyroid Eye Disease. The attendee should acquire a ground up systematic understanding of how to manage this complex disease and its protean manifestations. The seminar will be hybrid, available in person and virtually, although please be aware there are only a limited number of virtual places. In person delegates will get the opportunity to network and talk to the speakers during breaks and lunch. Please click Book now for the programme and prices.
Programme
09.30 – 10.00 Registration
10.00 – 10.05 Welcome
Miss Vickie Lee, London & Dr Claire Feeney, London (Chairs)
10.05 – 10.25 From bench to bedside – TED animal model.
Professor Anja Eckstein, Essen, Germany
10.25 – 10.45 Screening and assessment of TED
Miss Vickie Lee, London
10.45 – 11.05 Radiological assessment of TED
Dr Kunwar Bhatia, Consultant Head and Neck Radiologist, London
11.05 – 11.20 Q&A
11.20 - 11.40 Tea
11.40 - 12.00 Differential diagnosis of TED
Miss Anne Cook, Manchester
Therapies for TED
12.00 - 12.20 Optimising the Thyroid for TED management
Prof Karim Meeran, Professor of Endocrinology, London
12.20 - 12.40 Evidence based guidelines for Orbital Radiotherapy & Immunosuppression for TED
Miss Rashmi Akishar, London
12.40 - 12.55 Q&A
12.55 - 13.45 Lunch
13.45 - 14.05 Orbital & Eyelid surgery for TED
Miss Rebecca Ford, Bristol
14.05 - 14.25 Treatment of Diplopia in Thyroid Eye Disease
Professor Anja Eckstein, Essen. Germany
14.25 – 14.45 Emerging TED therapies
Professor Colin Dayan, Professor of Endocrinology, Cardiff
14.45 – 14.55 TEDct & Supporting our TED patients
Miss Rebecca Ford, Bristol
14.55 - 15.05 TEAMeD – 5 update
Professor Colin Dayan, Cardiff
15.05 - 15.20 Q&A
15.20– 15.40 Tea
15.40 - 16.40 Challenging Case Discussions
15.40 - 15.50 Mr Ahmad Aziz, London
15.50 - 16.00 Miss Anne Cook, Manchester
16.00 - 16.10 Miss Susie Morley, London
16.10 - 16.40 Panel discussion